Rhythm Pharmaceuticals, Inc. SEC filings RYTM
Rhythm Pharmaceuticals, Inc. has 837 filings in SEC EDGAR's recent list, going back to Aug 12, 2015. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 5, 2026 | — |
| S-3ASR | Automatic shelf registration | Feb 26, 2026 | — |
| S-8 | Employee stock plan registration | Feb 26, 2026 | — |
| S-8 | Employee stock plan registration | Jan 16, 2026 | — |
| 424B5 | Prospectus supplement | Jul 10, 2025 | — |
| 424B5 | Prospectus supplement | Jul 9, 2025 | — |
| S-8 | Employee stock plan registration | Feb 28, 2025 | — |
| 424B7 | Filing | Jul 10, 2024 | — |
| S-8 | Employee stock plan registration | Feb 29, 2024 | — |
| 424B5 | Prospectus supplement | Feb 29, 2024 | — |
| S-3ASR | Automatic shelf registration | Mar 2, 2023 | — |
| S-8 | Employee stock plan registration | Mar 2, 2023 | — |
| 424B5 | Prospectus supplement | Sep 15, 2022 | — |
| 424B5 | Prospectus supplement | Sep 14, 2022 | — |
| S-8 | Employee stock plan registration | Mar 1, 2022 | — |
| S-8 | Employee stock plan registration | Mar 1, 2022 | — |
| S-3 | Shelf registration | Nov 2, 2021 | — |
| S-8 | Employee stock plan registration | Mar 1, 2021 | — |
| 424B5 | Prospectus supplement | Feb 5, 2021 | — |
| 424B5 | Prospectus supplement | Feb 3, 2021 | — |
| S-8 | Employee stock plan registration | Mar 2, 2020 | — |
| 424B5 | Prospectus supplement | Oct 16, 2019 | — |
| 424B5 | Prospectus supplement | Oct 15, 2019 | — |
| S-8 | Employee stock plan registration | Feb 13, 2019 | — |
| S-3ASR | Automatic shelf registration | Nov 9, 2018 | — |
| 424B4 | Prospectus | Jun 21, 2018 | — |
| S-1MEF | Filing | Jun 20, 2018 | — |
| S-1/A | Amended registration statement | Jun 20, 2018 | — |
| S-1 | Registration statement | Jun 18, 2018 | — |
| S-8 | Employee stock plan registration | Mar 14, 2018 | — |
| S-8 | Employee stock plan registration | Oct 12, 2017 | — |
| 424B4 | Prospectus | Oct 5, 2017 | — |
| S-1MEF | Filing | Oct 4, 2017 | — |
| S-1/A | Amended registration statement | Sep 25, 2017 | — |
| S-1 | Registration statement | Sep 5, 2017 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RYTM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1649904
- Former names
- RHYTHM METABOLIC, INC. (until Aug 12, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.